Cargando…

Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure?

Detalles Bibliográficos
Autores principales:	Martín, Ernesto, Castillo, Juan C., González-Manzanares, Rafael, López-Aguilera, José, Perea, Jorge, Anguita, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2022
Materias:	Clinical Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890410/ https://www.ncbi.nlm.nih.gov/pubmed/34931694 http://dx.doi.org/10.5603/CJ.a2021.0169

Ejemplares similares

Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study
por: Martín, Ernesto, et al.
Publicado: (2021)

Acute on chronic heart failure—Which variations on B‐type natriuretic peptide levels?
por: Bettencourt, Paulo, et al.
Publicado: (2021)

Diagnostic Utility of N-terminal pro-Brain Natriuretic Peptide and C-reactive Protein in Diagnosing Heart Failure in Patients with Acute Hypoxemic Respiratory Failure
por: Abdullah, Azmat, et al.
Publicado: (2020)

Correlation of Vitamin D Deficiency With Severity of Chronic Heart Failure as Assessed by Functional Class and N-Terminal Pro-Brain Natriuretic Peptide Levels
por: Otaal, Parminder S, et al.
Publicado: (2021)

The Role of Brain Natriuretic Peptide as a Prognostic Marker for Sepsis
por: Bhandari, Binita, et al.
Publicado: (2020)

Decreased Renal Function is Associated with Heart Failure Readmissions
por: Vindhyal, Mohinder R, et al.
Publicado: (2018)

Does Heart Failure Mask Candida Tricuspid Endocarditis?
por: Mahmoud, Anas, et al.
Publicado: (2023)

Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide
por: Shah, Kevin, et al.
Publicado: (2010)

Snakebites in Pediatric Patients in Kahramanmaraş: Is Pro-brain Natriuretic Peptide a Prognostic Biomarker for Snakebites?
por: İpek, Sevcan, et al.
Publicado: (2022)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Stress-delta B-type Natriuretic Peptide Levels as a Test for Inducible Myocardial Ischemia: A Systematic Review and Meta-Analysis
por: Kheang, Sopagna, et al.
Publicado: (2020)

Utility of N-terminal (NT)-Brain Natriuretic Peptide (proBNP) in the Diagnosis and Prognosis of Pregnancy Associated Cardiovascular Conditions: A Systematic Review
por: Esbrand, Faith D, et al.
Publicado: (2022)

How Does It Work? Unraveling the Mysteries by Which Empagliflozin Helps Diabetic and Non-diabetic Patients With Heart Failure
por: Hernandez, Vernicia K, et al.
Publicado: (2023)

B‐type natriuretic peptide‐guided treatment for heart failure
por: McLellan, Julie, et al.
Publicado: (2016)

Impact of Mineralocorticoid Receptor Antagonists in the Treatment of Heart Failure: Targeting the Heart Failure Cascade
por: Jadhav, Uday, et al.
Publicado: (2023)

Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Heart Failure Treatments Such As Angiotensin Receptor/Neprilysin Inhibitor Improve Heart Failure Status and Glucose Metabolism
por: Kashiwagi, Yusuke, et al.
Publicado: (2022)

Cardiac Sarcoidosis-Induced Heart Failure
por: Figart, Michael W, et al.
Publicado: (2021)

Diuretic Resistance Associated With Heart Failure
por: Shams, Elham, et al.
Publicado: (2022)

Ultrafiltration in Heart Failure: A Review
por: Bisht, Himanshi, et al.
Publicado: (2023)

Acute Onset of Heart Failure and Renal Failure Due to Pacemaker Syndrome
por: Ashraf, Afreen, et al.
Publicado: (2023)

Suspecting Cardiac Amyloidosis in Congestive Heart Failure
por: Alatassi, Emad U, et al.
Publicado: (2020)

Role of Vasodilator Therapy in Acute Heart Failure
por: Batool, Aisha, et al.
Publicado: (2021)

Muscular Dystrophy and Heart Failure: An Unusual Association
por: Pais, João P, et al.
Publicado: (2021)

Palliative Care in Heart Failure: Challenging Prognostication
por: Egídio de Sousa, Inês, et al.
Publicado: (2021)

Soluble Guanylate Cyclase Stimulators in Heart Failure
por: Kansakar, Sajog, et al.
Publicado: (2021)

An Analysis of Epidemiological Factors in Heart Failure Outcomes
por: Patel, Karan, et al.
Publicado: (2022)

Cardiac Cachexia Associated With Valvular Heart Failure
por: Rodriguez-Guerra, Miguel A, et al.
Publicado: (2021)

Anemia and Heart Failure: A Narrative Review
por: Siddiqui, Shiza W, et al.
Publicado: (2022)

Inflammation as a Prognostic Marker in Heart Failure
por: Lima, Priscila C, et al.
Publicado: (2022)

Congestive Heart Failure 30-Day Readmission: Descriptive Study of Demographics, Co-morbidities, Heart Failure Knowledge, and Self-Care
por: Madanat, Luai, et al.
Publicado: (2021)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Essential components in natriuretic peptide-guided management of heart failure: an intervention synthesis
por: Oke, Jason, et al.
Publicado: (2018)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Risk Factors of Atrial Fibrillation in Patients with Heart Failure
por: Sarfraz, Alam, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_frr6lpmu7mebk918nivspj3eqd